Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2491-2496
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2491
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2491
Tumor cell lines | Chemotherapeuticdrugs | Concentration of Cantide (mmol/L) | |||
0.0 | 0.1 | 0.2 | 0.4 | ||
DDP | 0.45 | 0.36 | 0.27 | 0.15 | |
BGC | 5-FU | 10.28 | 7.84 | 2.17 | 1.70 |
ADM | 0.60 | 0.43 | 0.38 | 0.11 | |
DDP | 5.43 | 3.21 | 2.04 | 0.96 | |
A549 | 5-FU | 9.69 | 9.06 | 5.34 | 0.31 |
ADM | 0.76 | 0.71 | 0.60 | 0.43 |
Group | Tumor weight (g) | Inhibitory rate (%) |
Control | 2.17±0.31 | 0.0 |
Cantide | 1.05±0.16 | 51.6 |
DDP | 1.13±0.09 | 47.9 |
Cantide+DDP | 0.65±0.19 | 70.0 |
-
Citation: Yang Y, Lv QJ, Du QY, Yang BH, Lin RX, Wang SQ. Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells’ growth
in vitro andin vivo . World J Gastroenterol 2005; 11(16): 2491-2496 - URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2491.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2491